SYRS

Syros Pharmaceuticals, Inc. Common Stock
SYRS

Overview Fund Activity
Delisted

SYRS was delisted on the 19th of March, 2025.

Back to rankings

64 hedge funds and large institutions have $40.7M invested in Syros Pharmaceuticals, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-6
Holders Change %
-8.57%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
11
Increased
11
Reduced
15
Closed
17
Calls
$281K
Puts
$2.73M
Net Calls
-$2.45M
Net Calls Change
-$2.58M

Top Buyers

1
BOCH
1
Blue Owl Capital Holdings
New York
$1.11M
2
EAM
2
Exome Asset Management
New York
$642K
3
UOC
3
UBS O'Connor
Illinois
$773K
4
Qube Research & Technologies (QRT)
4
Qube Research & Technologies (QRT)
United Kingdom
$167K
5
ECM
5
ExodusPoint Capital Management
New York
$673K

Top Sellers

1
AG
1
Artal Group
Luxembourg
$0
2
KCM
2
Kennedy Capital Management
Missouri
$0
3
Goldman Sachs
3
Goldman Sachs
New York
$0
4
APM
4
Avidity Partners Management
Texas
$2.29M
5
DCM
5
DAFNA Capital Management
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
76
Simplex Trading
Illinois
– -$72K -14,091 Closed
EDRH
77
Edmond de Rothschild Holding
Switzerland
– -$22.6K -4,382 Closed
RWMG
78
Redwood Wealth Management Group
New Jersey
– -$5.97K -1,157 Closed
National Bank of Canada
79
National Bank of Canada
Quebec, Canada
– -$4.23K -859 Closed
RhumbLine Advisers
80
RhumbLine Advisers
Massachusetts
– -$3.4K -659 Closed
AF
81
Aviso Financial
Ontario, Canada
– -$108 -21 Closed
1 2 3
4